gdc

May 2018 Cancer Biomarkers and Molecular Testing

What Are Cancer Biomarkers, and Why Are They Important?
Cancer BiomarkersCancer Screening
Biomarkers are biologic markers that indicate changes in our genes and may increase the risk of cancer.
My Biomarker Story, and Why I Advocate for Genetic Testing
Patient AdvocacyPatient StoriesCancer Biomarkers
Wenora Y. Johnson, 3-time survivor, shares her cancer story and encourages patients to ask their care team about biomarker testing.
FDA Approves First Direct-to-Consumer Genetic Test for 3 Types of BRCA Mutations in Men and Women
Cancer ScreeningFDA NewsNewsworthy
This first-ever direct-to-consumer genetic test can provide information on potential risks to individuals who may not have access to genetic screening, but the information may be misleading without feedback from experts.
From Silent Voices to “Hear My Voice”: People Living with Metastatic Breast Cancer Are Speaking Out
Breast Cancer
A national advocacy program trains patients with metastatic breast cancer to educate the public about the special needs of patients with advanced breast cancer.
What Are Biomarkers in Breast Cancer, and How Do They Affect My Treatment? Interview with Daniel F. Hayes, MD, FACP, FASCO
Breast CancerCancer BiomarkersCancer Screening
Dr Hayes, Immediate Past President of ASCO and Professor of Breast Cancer Research at the University of Michigan Comprehensive Cancer Center, explains how biomarkers offer more precise treatment opportunities for patients with breast cancer.
Cancer Genetics or Genomics — Is There a Difference?
Genetics & Cancer
The terms genetics and genomics are often used interchangeably in relation to cancer, but they refer to different things and are becoming very important in cancer treatment.
New Developments in Cancer Biomarkers Reported at AACR 2018
Cancer Biomarkers
Read about important advancements in tumor biomarkers and their role in guiding treatment in some types of cancer.
New Blood Test Screens for 8 Types of Cancer and 16 Genomic Mutations
Cancer Screening
CancerSEEK is a noninvasive blood test that may help detect cancer in early stages, when treatment has the highest chance for success.
“Liquid Biopsy” May Help to Personalize Treatment for Patients with Cancer
Cancer Screening
Liquid biopsy is a noninvasive blood test that can help identify cancerous cells or biomarkers, such as gene mutations that may respond to targeted therapies.
Targeted Therapies: Finding the Key to Managing Non–Small-Cell Lung Cancer
Lung Cancer
Targeted therapies for lung cancer are newer therapies designed to target specific types of genetic mutations found in some patients, and improve the response to treatment.
Growing Role of Biomarkers in the Treatment of Patients with Acute Myeloid Leukemia
Cancer BiomarkersLeukemia
In recent years, new treatments for acute myeloid leukemia have improved outcomes. In 2017, 2 new drugs were approved for patients with this type of blood cancer linked to a specific biomarker.
Understanding dMMR and MSI-H Tumor Biomarkers
Cancer Biomarkers
The understanding of the role of dMMR or MSI-H biomarkers in cancer has led to the first approval of a cancer drug based on a biomarker instead of a specific tumor type.
Page 1 of 2
Results 1 - 12 of 21

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country